Quantitative PCR used to assess HIV-1 integration and 2-LTR circle formation in human macrophages, peripheral blood lymphocytes and a CD4+ cell line

Virology Journal

Volumn 7, Issue , 2010, Pages

  Friedrich, Brian ^a   Li, Guangyu ^a   Dziuba, Natallia ^a   Ferguson, Monique R ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; RALTEGRAVIR; VIRUS DNA;

ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MACROPHAGE; PERIPHERAL LYMPHOCYTE; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; VIRUS DNA CELL DNA INTERACTION; VIRUS STRAIN; CELL CULTURE; EVALUATION; GENETICS; LONG TERMINAL REPEAT; METHODOLOGY; PHYSIOLOGY; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; VIROLOGY; VIRUS GENOME;

HUMAN IMMUNODEFICIENCY VIRUS 1;

CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; DNA, COMPLEMENTARY; DNA, VIRAL; GENOME, VIRAL; HIV LONG TERMINAL REPEAT; HIV-1; HUMANS; MACROPHAGES; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; VIROLOGY; VIRUS INTEGRATION;

EID: 78649602770     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-7-354     Document Type: Article

References (27)

1. Potential role for CD63 in CCR5-mediated human immunodeficiency virus type 1 infection of macrophages. JJ von Lindern D Rojo K Grovit-Ferbas C Yeramian C Deng G Herbein MR Ferguson TC Pappas JM Decker A Singh,, et al. J Virol 2003 77 3624 3633 10.1128/JVI.77.6.3624-3633.2003 12610138
2. Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy. H Zhang G Dornadula M Beumont L Livornese Jr B Van Uitert K Henning RJ Pomerantz, N Engl J Med 1998 339 1803 1809 10.1056/NEJM199812173392502 9854115
3. Genotypic and phenotypic characterization of HIV-1 patients with primary infection. T Zhu H Mo N Wang DS Nam Y Cao RA Koup DD Ho, Science 1993 261 1179 1181 10.1126/science.8356453 8356453
4. The role of mononuclear phagocytes in HTLV-III/LAV infection. S Gartner P Markovits DM Markovitz MH Kaplan RC Gallo M Popovic, Science 1986 233 215 219 10.1126/science.3014648 3014648
5. Macrophages: do they impact AIDS progression more than CD4 T cells? MJ Kuroda, J Leukoc Biol 87 569 573 10.1189/jlb.0909626 20053708
6. Multiple effects of mutations in human immunodeficiency virus type 1 integrase on viral replication. A Engelman G Englund JM Orenstein MA Martin R Craigie, J Virol 1995 69 2729 2736 7535863
7. Integration is required for productive infection of monocyte-derived macrophages by human immunodeficiency virus type 1. G Englund TS Theodore EO Freed A Engelman MA Martin, J Virol 1995 69 3216 3219 7707554
8. Requirement of active human immunodeficiency virus type 1 integrase enzyme for productive infection of human T-lymphoid cells. RL LaFemina CL Schneider HL Robbins PL Callahan K LeGrow E Roth WA Schleif EA Emini, J Virol 1992 66 7414 7419 1433523
9. Integration is essential for efficient gene expression of human immunodeficiency virus type 1. H Sakai M Kawamura J Sakuragi S Sakuragi R Shibata A Ishimoto N Ono S Ueda A Adachi, J Virol 1993 67 1169 1174 8437208
10. HIV-1 replication is controlled at the level of T cell activation and proviral integration. M Stevenson TL Stanwick MP Dempsey CA Lamonica, Embo J 1990 9 1551 1560 2184033
11. Human immunodeficiency virus type 1 2-LTR circles reside in a nucleoprotein complex which is different from the preintegration complex. M Bukrinsky N Sharova M Stevenson, J Virol 1993 67 6863 6865 8411390
12. Circularization of human immunodeficiency virus type 1 DNA in vitro. CM Farnet WA Haseltine, J Virol 1991 65 6942 6952 1834863
13. Identification of host proteins required for HIV infection through a functional genomic screen. AL Brass DM Dykxhoorn Y Benita N Yan A Engelman RJ Xavier J Lieberman SJ Elledge, Science 2008 319 921 926 10.1126/science.1152725 18187620
14. Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. R Konig Y Zhou D Elleder TL Diamond GM Bonamy JT Irelan CY Chiang BP Tu PD De Jesus CE Lilley,, et al. Cell 2008 135 49 60 10.1016/j.cell.2008.07.032 18854154
15. Human immunodeficiency virus type 1 replication is blocked prior to reverse transcription and integration in freshly isolated peripheral blood monocytes. S Sonza A Maerz N Deacon J Meanger J Mills S Crowe, J Virol 1996 70 3863 3869 8648722
16. Kinetics of human immunodeficiency virus type 1 (HIV) DNA integration in acutely infected cells as determined using a novel assay for detection of integrated HIV DNA. N Vandegraaff R Kumar CJ Burrell P Li, J Virol 2001 75 11253 11260 10.1128/JVI.75.22.11253-11260.2001 11602768
17. Analysis of human immunodeficiency virus type 1 integration by using a specific, sensitive and quantitative assay based on real-time polymerase chain reaction. N Yamamoto C Tanaka Y Wu MO Chang Y Inagaki Y Saito T Naito H Ogasawara I Sekigawa Y Hayashida, Virus Genes 2006 32 105 113 10.1007/s11262-005-5851-2 16525741
18. Detecting HIV-1 integration by repetitive-sampling Alu-gag PCR. MK Liszewski JJ Yu U O'Doherty, Methods 2009 47 254 260 10.1016/j.ymeth.2009.01.002 19195495
19. A sensitive, quantitative assay for human immunodeficiency virus type 1 integration. U O'Doherty WJ Swiggard D Jeyakumar D McGain MH Malim, J Virol 2002 76 10942 10950 10.1128/JVI.76.21.10942-10950.2002 12368337
20. Antiretroviral therapy with the integrase inhibitor raltegravir alters decay kinetics of HIV, significantly reducing the second phase. JM Murray S Emery AD Kelleher M Law J Chen DJ Hazuda BY Nguyen H Teppler DA Cooper, Aids 2007 21 2315 2321 10.1097/QAD.0b013e3282f12377 18090280
21. Discovery of raltegravir, a potent, selective orally bioavailable HIV-integrase inhibitor for the treatment of HIV-AIDS infection. V Summa A Petrocchi F Bonelli B Crescenzi M Donghi M Ferrara F Fiore C Gardelli O Gonzalez Paz DJ Hazuda,, et al. J Med Chem 2008 51 5843 5855 10.1021/jm800245z 18763751
22. A more precise HIV integration assay designed to detect small differences finds lower levels of integrated DNA in HAART treated patients. JJ Yu TL Wu MK Liszewski J Dai WJ Swiggard C Baytop I Frank BL Levine W Yang T Theodosopoulos U O'Doherty, Virology 2008 379 78 86 10.1016/j.virol.2008.05.030 18649912
23. Cofactor requirement for human immunodeficiency virus type 1 entry into a CD4-expressing human cell line. RD Harrington AP Geballe, J Virol 1993 67 5939 5947 7690415
24. Indicator cell lines for detection of primary strains of human and simian immunodeficiency viruses. MA Vodicka WC Goh LI Wu ME Rogel SR Bartz VL Schweickart CJ Raport M Emerman, Virology 1997 233 193 198 10.1006/viro.1997. 8606 9201229
25. HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domain. WA O'Brien Y Koyanagi A Namazie JQ Zhao A Diagne K Idler JA Zack IS Chen, Nature 1990 348 69 73 10.1038/348069a0 2172833
26. Increased susceptibility of differentiated mononuclear phagocytes to productive infection with human immunodeficiency virus-1 (HIV-1). EA Rich IS Chen JA Zack ML Leonard WA O'Brien, J Clin Invest 1992 89 176 183 10.1172/JCI115559 1370293
27. A quantitative assay for HIV DNA integration in vivo. SL Butler MS Hansen FD Bushman, Nat Med 2001 7 631 634 10.1038/87979 11329067